Study on Lung Cancer in Young Adults
Biology of Young Lung Cancer Study: The YOUNG LUNG Study
Recruiting
Observational Study
Non Small Cell Lung Cancer
Small Cell Lung Carcinoma
NUT Carcinoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 15 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 500 (estimated)
- Sponsor
- Dana-Farber Cancer Institute · Other
Who this trial is looking for
This trial is looking for adults aged 45 or younger who have been diagnosed with lung cancer. Participants will provide some blood samples and share their diagnosis details.
Are You a Good Fit for This Trial?
You may be able to join if
- I am 45 years old or younger at the time of my lung cancer diagnosis.
- I have been diagnosed with bronchogenic lung carcinoma.
- I can give written consent to participate.
- I am willing to have blood drawn up to two times in a four-week period.
- I understand that I can be under 18 if I meet certain criteria and have parental consent.
You may not be able to join if
- I do not want to sign the consent form.
- I am unable to give consent and do not have someone to help me.
- Using my tissue for research would affect my diagnosis or staging.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this research study is to learn more about lung cancer (NSCLC or SCLC) diagnosed in adults at ages 45 or younger.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 45 and under at lung cancer diagnosis
* Pathologically confirmed bronchogenic lung carcinoma (NSCLC or SCLC of any stage) at any treatment time point
* Provision of written informed consent
* Willingness to undergo no more than two (2) peripheral blood draws in a four (4) …
Contacts